RadNet Inc. (RDNT) EVP Sells $49,800.00 in Stock

RadNet Inc. (NASDAQ:RDNT) EVP Norman R. Hames sold 5,000 shares of the company’s stock in a transaction dated Wednesday, December 20th. The shares were sold at an average price of $9.96, for a total transaction of $49,800.00. Following the completion of the sale, the executive vice president now directly owns 365,087 shares in the company, valued at $3,636,266.52. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website.

Shares of RadNet Inc. (RDNT) remained flat at $$10.00 on Friday. 119,585 shares of the stock were exchanged, compared to its average volume of 238,785. RadNet Inc. has a one year low of $5.25 and a one year high of $11.90. The firm has a market cap of $476.24, a price-to-earnings ratio of 43.48, a price-to-earnings-growth ratio of 3.36 and a beta of 0.82. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 7.88.

RadNet (NASDAQ:RDNT) last announced its quarterly earnings results on Thursday, November 9th. The medical research company reported $0.12 EPS for the quarter, meeting the Zacks’ consensus estimate of $0.12. RadNet had a net margin of 1.21% and a return on equity of 23.73%. The business had revenue of $227.60 million for the quarter, compared to analyst estimates of $232.84 million. During the same quarter in the prior year, the business earned $0.11 EPS. RadNet’s quarterly revenue was up 1.3% on a year-over-year basis. equities research analysts predict that RadNet Inc. will post 0.35 EPS for the current year.

Institutional investors and hedge funds have recently made changes to their positions in the stock. Airain ltd acquired a new position in RadNet in the 2nd quarter valued at about $100,000. Bank of America Corp DE grew its position in shares of RadNet by 5.9% during the 1st quarter. Bank of America Corp DE now owns 26,580 shares of the medical research company’s stock worth $157,000 after purchasing an additional 1,477 shares in the last quarter. Prudential Financial Inc. grew its position in shares of RadNet by 15.2% during the 2nd quarter. Prudential Financial Inc. now owns 20,410 shares of the medical research company’s stock worth $158,000 after purchasing an additional 2,700 shares in the last quarter. Parallax Volatility Advisers L.P. grew its position in shares of RadNet by 122.0% during the 2nd quarter. Parallax Volatility Advisers L.P. now owns 21,122 shares of the medical research company’s stock worth $164,000 after purchasing an additional 117,148 shares in the last quarter. Finally, Voya Investment Management LLC grew its position in shares of RadNet by 19.5% during the 2nd quarter. Voya Investment Management LLC now owns 21,726 shares of the medical research company’s stock worth $168,000 after purchasing an additional 3,546 shares in the last quarter. Institutional investors and hedge funds own 53.16% of the company’s stock.

A number of brokerages have recently issued reports on RDNT. Zacks Investment Research cut shares of RadNet from a “hold” rating to a “sell” rating in a report on Tuesday, November 14th. TheStreet lowered shares of RadNet from a “b-” rating to a “c” rating in a research note on Friday, October 27th.

TRADEMARK VIOLATION WARNING: This piece of content was reported by Community Financial News and is the property of of Community Financial News. If you are accessing this piece of content on another domain, it was illegally stolen and republished in violation of U.S. & international copyright and trademark laws. The legal version of this piece of content can be accessed at https://www.com-unik.info/2017/12/23/radnet-inc-rdnt-evp-sells-49800-00-in-stock.html.

RadNet Company Profile

RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.

Insider Buying and Selling by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet and related companies with MarketBeat.com's FREE daily email newsletter.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit